{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:25:15Z","timestamp":1787160315519,"version":"build-2736575974"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["101016167"],"award-info":[{"award-number":["101016167"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["101045989"],"award-info":[{"award-number":["101045989"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.virol.2025.110584","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T19:09:47Z","timestamp":1748286587000},"page":"110584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Drivers of quasispecies development in SARS-CoV-2 and implications for emergent variants and COVID-19"],"prefix":"10.1016","volume":"610","author":[{"given":"Mathias","family":"Smet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilda","family":"Berkell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"G\u00f3rska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelina","family":"Tacconelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Kumar-Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8699-8905","authenticated-orcid":false,"given":"Surbhi","family":"Malhotra-Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.virol.2025.110584_bib1","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-03996-w","article-title":"Global landscape of SARS-CoV-2 mutations and conserved regions","volume":"21","author":"Abbasian","year":"2023","journal-title":"J. Transl. Med."},{"issue":"November 2002","key":"10.1016\/j.virol.2025.110584_bib2","article-title":"Comparative review of SARS-CoV-2, SARS-CoV, MERS-CoV, and influenza A respiratory viruses","volume":"11","author":"Abdelrahman","year":"2020","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.virol.2025.110584_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105438","article-title":"Comparative analysis of within-host diversity among vaccinated COVID-19 patients infected with different SARS-CoV-2 variants","volume":"25","author":"Al-Khatib","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.virol.2025.110584_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/v14010078","article-title":"The remarkable evolutionary plasticity of coronaviruses by mutation and recombination: insights for the COVID-19 pandemic and the future evolutionary paths of SARS-CoV-2","volume":"14","author":"Amoutzias","year":"2022","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.virol.2025.110584_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/genes13030552","article-title":"Coronavirus genomes and unique mutations in structural and non-structural proteins in Pakistani SARS-CoV-2 delta variants during the fourth wave of the pandemic","volume":"13","author":"Anwar","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.virol.2025.110584_bib6","article-title":"Rapid spread of the SARS-CoV-2 Omicron XDR lineage derived from recombination between XBB and BA.2.86 subvariants circulating in Brazil in late 2023","volume":"vol. 13","author":"Arantes","year":"2025"},{"key":"10.1016\/j.virol.2025.110584_bib7","first-page":"13","article-title":"A rapid, whole genome sequencing assay for detection and characterization of novel coronavirus (SARS-CoV-2) clinical specimens using nanopore sequencing","author":"Ar\u00e9valo","year":"2022","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.virol.2025.110584_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/v13010133","article-title":"Intra-host diversity of sars-cov-2 should not be neglected: case of the state of Victoria, Australia","volume":"13","author":"Armero","year":"2021","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/j.virol.2025.110584_bib9","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1089\/dna.2020.5703","article-title":"The novel insight of SARS-CoV-2 molecular biology and pathogenesis and therapeutic options","volume":"39","author":"Asghari","year":"2020","journal-title":"DNA Cell Biol."},{"issue":"24","key":"10.1016\/j.virol.2025.110584_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415658","article-title":"Quasispecies analysis of SARS-CoV-2 of 15 different lineages during the first year of the pandemic prompts scratching under the surface of consensus genome sequences","volume":"23","author":"Bader","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virol.2025.110584_bib11","author":"Berkell"},{"issue":"2","key":"10.1016\/j.virol.2025.110584_bib12","doi-asserted-by":"crossref","first-page":"E357","DOI":"10.9778\/cmajo.20220026","article-title":"Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study","volume":"10","author":"Bhatt","year":"2022","journal-title":"CMAJ Open"},{"key":"10.1016\/j.virol.2025.110584_bib13","doi-asserted-by":"crossref","unstructured":"Bloom JD, Beichman AC, Neher RA, Harris K. Evolution of the SARS-CoV-2 Mutational Spectrum. Available from: https:\/\/doi.org\/10.1093\/molbev\/msad085.","DOI":"10.1093\/molbev\/msad085"},{"issue":"21","key":"10.1016\/j.virol.2025.110584_bib14","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1016\/j.cell.2023.08.026","article-title":"SARS-CoV-2 variants evolve convergent strategies to remodel the host response","volume":"186","author":"Bouhaddou","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.virol.2025.110584_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00692-24","article-title":"Defective viral genomes: advances in understanding their generation, function, and impact on infection outcomes","volume":"15","author":"Brennan","year":"2024","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.virol.2025.110584_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/s12864-022-08652-z","article-title":"SARS-CoV-2 Delta variant isolates from vaccinated individuals","volume":"23","author":"Brinkac","year":"2022","journal-title":"BMC Genom."},{"issue":"1","key":"10.1016\/j.virol.2025.110584_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/ve\/veac042","article-title":"Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host","volume":"8","author":"Caccuri","year":"2022","journal-title":"Virus Evol."},{"issue":"1","key":"10.1016\/j.virol.2025.110584_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-24918-8","article-title":"The frequency of defective genomes in Omicron differs from that of the Alpha, Beta and Delta variants","volume":"12","author":"Campos","year":"2022","journal-title":"Sci. Rep."},{"issue":"7948","key":"10.1016\/j.virol.2025.110584_bib19","first-page":"521","article-title":"Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution","volume":"614","author":"Cao","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.virol.2025.110584_bib20","first-page":"162","article-title":"SARS-CoV-2 variant biology: immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virol.2025.110584_bib21","volume":"13","author":"Chakraborty","year":"2021","journal-title":"J. Antivir. Antiretrovir."},{"key":"10.1016\/j.virol.2025.110584_bib22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ijid.2022.05.016","article-title":"The role of children in household transmission of COVID-19: a systematic review and meta-analysis","volume":"122","author":"Chen","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.virol.2025.110584_bib23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ijid.2022.05.016","article-title":"The role of children in household transmission of COVID-19: a systematic review and meta-analysis","volume":"122","author":"Chen","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.virol.2025.110584_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29209","article-title":"From viral democratic genomes to viral wild bunch of quasispecies","volume":"95","author":"Colson","year":"2023","journal-title":"J. Med. Virol."},{"issue":"11","key":"10.1016\/j.virol.2025.110584_bib25","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1002\/jmv.27964","article-title":"Temporal changes in the accessory protein mutations of SARS-CoV-2 variants and their predicted structural and functional effects","volume":"94","author":"Cruz","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2025.110584_bib26","author":"Destras"},{"issue":"10","key":"10.1016\/j.virol.2025.110584_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008271","article-title":"Viral quasispecies","volume":"15","author":"Domingo","year":"2019","journal-title":"PLoS Genet."},{"issue":"12","key":"10.1016\/j.virol.2025.110584_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01511-23","article-title":"Puzzles, challenges, and information reservoir of SARS-CoV-2 quasispecies","volume":"97","author":"Domingo","year":"2023","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2025.110584_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22060-z","article-title":"SARS-CoV-2 quasi-species analysis from patients with persistent nasopharyngeal shedding","volume":"12","author":"Dudouet","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2025.110584_bib30","author":"Duerr"},{"key":"10.1016\/j.virol.2025.110584_bib31","doi-asserted-by":"crossref","unstructured":"Eigen M. DIE NATURWISSENSCHAFTEN 58. Jahrgang, 197t Selforganization of Matter and the Evolution of Biological Macromolecules...","DOI":"10.1007\/BF00623322"},{"key":"10.1016\/j.virol.2025.110584_bib32","series-title":"Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibody for Treatment of COVID-19","year":"2020"},{"key":"10.1016\/j.virol.2025.110584_bib33","series-title":"FDA Authorizes Bamlanivimab and Etesevimab Monoclonal Antibody Therapy for Post-exposure Prophylaxis (Prevention) for COVID-19","year":"2021"},{"key":"10.1016\/j.virol.2025.110584_bib34","series-title":"Coronavirus (COVID-19) Update: FDA Authorizes New Long-Acting Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in Certain Individuals","year":"2021"},{"key":"10.1016\/j.virol.2025.110584_bib35","series-title":"FDA Authorizes REGEN-COV Monoclonal Antibody Therapy for Post-exposure Prophylaxis (Prevention) for COVID-19","year":"2024"},{"issue":"5","key":"10.1016\/j.virol.2025.110584_bib36","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1016\/S2666-5247(23)00393-2","article-title":"Effect of molnupiravir on SARS-CoV-2 evolution in immunocompromised patients: a retrospective observational study","volume":"5","author":"Fountain-Jones","year":"2024","journal-title":"Lancet Microbe"},{"issue":"4","key":"10.1016\/j.virol.2025.110584_bib37","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41592-023-01769-3","article-title":"Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations","volume":"20","author":"Gangavarapu","year":"2023","journal-title":"Nat. Methods"},{"issue":"15","key":"10.1016\/j.virol.2025.110584_bib38","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1111\/bph.16344","article-title":"Synergism between remdesivir and ribavirin leads to SARS-CoV-2 extinction in cell culture","volume":"181","author":"Garc\u00eda-Crespo","year":"2024","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.virol.2025.110584_bib39","article-title":"Exploration of low-frequency allelic variants of SARS-CoV-2 genomes reveals coinfections in Mexico occurred during periods of VOCs turnover","volume":"10","author":"Garc\u00eda-L\u00f3pez","year":"2024","journal-title":"Microb. Genom."},{"key":"10.1016\/j.virol.2025.110584_bib40","author":"Genoyer"},{"issue":"1","key":"10.1016\/j.virol.2025.110584_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009226","article-title":"The coronavirus proofreading exoribonuclease mediates extensive viral recombination","volume":"17","author":"Gribble","year":"2021","journal-title":"PLoS Pathog."},{"issue":"5","key":"10.1016\/j.virol.2025.110584_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29642","article-title":"Molnupiravir increases SARS-CoV-2 genome diversity and complexity: a case-control cohort study","volume":"96","author":"Gruber","year":"2024","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.virol.2025.110584_bib43","article-title":"Within-host genetic diversity of SARS-CoV-2 lineages in unvaccinated and vaccinated individuals","volume":"14","author":"Gu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2025.110584_bib44","author":"Gupta"},{"key":"10.1016\/j.virol.2025.110584_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105699","article-title":"Unique mutations in SARS-CoV-2 Omicron subvariants' non-spike proteins: potential impacts on viral pathogenesis and host immune evasion","volume":"170","author":"Hossain","year":"2022","journal-title":"Microb. Pathog."},{"issue":"NA","key":"10.1016\/j.virol.2025.110584_bib46","article-title":"Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany","volume":"8","author":"Jensen","year":"2021","journal-title":"The Lancet regional health Europe"},{"issue":"10475","key":"10.1016\/j.virol.2025.110584_bib47","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(24)02864-2","article-title":"Undervaccination and severe COVID-19 outcomes","volume":"405","author":"Joffe","year":"2025","journal-title":"The Lancet [Internet]"},{"issue":"1","key":"10.1016\/j.virol.2025.110584_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-40463-4","article-title":"Comparison of genome replication fidelity between SARS-CoV-2 and influenza A virus in cell culture","volume":"13","author":"Kawasaki","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2025.110584_bib49","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/jmv.25798","article-title":"Novel coronavirus treatment with ribavirin: groundwork for an evaluation concerning COVID-19. Vol. 92","author":"Khalili","year":"2020","journal-title":"J. Med. Virol."},{"issue":"12","key":"10.1016\/j.virol.2025.110584_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/v14122775","article-title":"Multiple mutations associated with emergent variants can Be detected as low-frequency mutations in early SARS-CoV-2 pandemic clinical samples","volume":"14","author":"Kimbrel","year":"2022","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.virol.2025.110584_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-51539-8","article-title":"Rapid intra-host diversification and evolution of SARS-CoV-2 in advanced HIV infection","volume":"15","author":"Ko","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2025.110584_bib52","doi-asserted-by":"crossref","unstructured":"Kuipers J, Batavia AA, Philipp Jablonski K, Bayer F, Borgsm\u00fcller N, Dondi A, et al. Within-patient genetic diversity of SARS-CoV-2. :2. Available from: https:\/\/doi.org\/10.1101\/2020.10.12.335919.","DOI":"10.1101\/2020.10.12.335919"},{"key":"10.1016\/j.virol.2025.110584_bib53","series-title":"SOTROVIMAB Letter of Authorization - 02\/23\/2022 - REVOKED","author":"Lake","year":"2022"},{"issue":"10","key":"10.1016\/j.virol.2025.110584_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9102145","article-title":"SARS-CoV-2 evolution among oncological population: in-depth virological analysis of a clinical cohort","volume":"9","author":"Laubscher","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.virol.2025.110584_bib55","unstructured":"Lederberg J, Lederberg EM. REPLICA PLATING AND INDIRECT SELECTION OF BACTERIAL MUTANTS [Internet]. Available from: https:\/\/journals.asm.org\/journal\/jb."},{"issue":"6","key":"10.1016\/j.virol.2025.110584_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00254-22","article-title":"Population pharmacokinetics of remdesivir and GS-441524 in hospitalized COVID-19 patients","volume":"66","author":"Leegwater","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2025.110584_bib57","article-title":"Evolution of the SARS-CoV-2 omicron variants: genetic impact on viral fitness","volume":"16","author":"Liu","year":"2024","journal-title":"Viruses"},{"issue":"6539","key":"10.1016\/j.virol.2025.110584_bib58","article-title":"SARS-CoV-2 within-host diversity and transmission","volume":"372","author":"Lythgoe","year":"2021","journal-title":"Science (1979)"},{"key":"10.1016\/j.virol.2025.110584_bib59","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13732","article-title":"Molnupiravir: mechanism of action, clinical, and translational science","volume":"17","author":"Maas","year":"2024","journal-title":"Clinical and Translational Science"},{"key":"10.1016\/j.virol.2025.110584_bib60","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41580-021-00432-z","article-title":"Structures and functions of coronavirus replication\u2013transcription complexes and their relevance for SARS-CoV-2 drug design","volume":"23","author":"Malone","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.virol.2025.110584_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/v16030447","article-title":"Immune system deficiencies do not alter SARS-CoV-2 evolutionary rate but favour the emergence of mutations by extending viral persistence","volume":"16","author":"Manuto","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2025.110584_bib62","series-title":"Nature Reviews Microbiology","first-page":"361","article-title":"The evolution of SARS-CoV-2. Vol. 21","author":"Markov","year":"2023"},{"issue":"6","key":"10.1016\/j.virol.2025.110584_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens11060662","article-title":"SARS-CoV-2 mutant spectra at different depth levels reveal an overwhelming abundance of low frequency mutations","volume":"11","author":"Mart\u00ednez-Gonz\u00e1lez","year":"2022","journal-title":"Pathogens"},{"issue":"6","key":"10.1016\/j.virol.2025.110584_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28848","article-title":"Traceability of SARS-CoV-2 transmission through quasispecies analysis","volume":"95","author":"Messali","year":"2023","journal-title":"J. Med. Virol."},{"issue":"5","key":"10.1016\/j.virol.2025.110584_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/v13050751","article-title":"Within-host and between-host evolution in sars-cov-2\u2014new variant's source","volume":"13","author":"Moelling","year":"2021","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.virol.2025.110584_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-022-00992-2","article-title":"Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events","volume":"7","author":"Ou","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.virol.2025.110584_bib67","series-title":"Letter of Revoking Remdesivir","author":"O'Shaughnessy","year":"2022"},{"key":"10.1016\/j.virol.2025.110584_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2021.104973","article-title":"Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades","volume":"93","author":"Patro","year":"2021","journal-title":"Infect. Genet. Evol."},{"issue":"1","key":"10.1016\/j.virol.2025.110584_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-43391-z","article-title":"Systematic detection of co-infection and intra-host recombination in more than 2 million global SARS-CoV-2 samples","volume":"15","author":"Pipek","year":"2024","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.virol.2025.110584_bib70","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1002\/jmv.26626","article-title":"Evolutionary dynamics of SARS-CoV-2 nucleocapsid protein and its consequences","volume":"93","author":"Rahman","year":"2021","journal-title":"J. Med. Virol."},{"issue":"15","key":"10.1016\/j.virol.2025.110584_bib71","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMc2120219","article-title":"Resistance mutations in SARS-CoV-2 delta variant after sotrovimab use","volume":"386","author":"Rockett","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.virol.2025.110584_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/s43856-023-00320-x","article-title":"Evolutionary implications of SARS-CoV-2 vaccination for the future design of vaccination strategies","volume":"3","author":"Rouzine","year":"2023","journal-title":"Commun. Med."},{"key":"10.1016\/j.virol.2025.110584_bib73","author":"Sardany\u00e9s"},{"issue":"6","key":"10.1016\/j.virol.2025.110584_bib74","doi-asserted-by":"crossref","DOI":"10.1111\/irv.13340","article-title":"Identification of various recombinants in a patient coinfected with the different SARS-CoV-2 variants","volume":"18","author":"Sayama","year":"2024","journal-title":"Influenza Other Respir Viruses"},{"issue":"1","key":"10.1016\/j.virol.2025.110584_bib75","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/22221751.2021.1922097","article-title":"Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications","volume":"10","author":"Shen","year":"2021","journal-title":"Emerg. Microb. Infect."},{"issue":"2","key":"10.1016\/j.virol.2025.110584_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28519","article-title":"Enhanced recombination among Omicron subvariants of SARS-CoV-2 contributes to viral immune escape","volume":"95","author":"Shiraz","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2025.110584_bib77","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2381","article-title":"Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: implications for immune escape and transmission","volume":"32","author":"Shrestha","year":"2022","journal-title":"Rev. Med. Virol."},{"issue":"2","key":"10.1016\/j.virol.2025.110584_bib78","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00705-021-05320-7","article-title":"Emergence of two distinct variants of SARS-CoV-2 and an explosive second wave of COVID-19: the experience of a tertiary care hospital in Pune, India","volume":"167","author":"Shrivastava","year":"2022","journal-title":"Arch. Virol."},{"issue":"1","key":"10.1016\/j.virol.2025.110584_bib79","doi-asserted-by":"crossref","DOI":"10.1093\/ve\/veab013","article-title":"SARS-CoV-2 genomic analyses in cancer patients reveal elevated intrahost genetic diversity","volume":"7","author":"Siqueira","year":"2021","journal-title":"Virus Evol."},{"key":"10.1016\/j.virol.2025.110584_bib80","unstructured":"Smit J, Nacer E, Sikorski A, Goddard C, Magdziarz W. Social and Economic Consequences of COVID-19."},{"key":"10.1016\/j.virol.2025.110584_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/s41579-023-01003-z","article-title":"SARS-CoV-2 Biology and Host Interactions","author":"Steiner","year":"2024"},{"issue":"1","key":"10.1016\/j.virol.2025.110584_bib82","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00261-21","article-title":"SARS-CoV-2 quasispecies provides an advantage mutation pool for the epidemic variants","volume":"9","author":"Sun","year":"2021","journal-title":"Microbiol. Spectr."},{"issue":"1","key":"10.1016\/j.virol.2025.110584_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-38435-3","article-title":"Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants","volume":"14","author":"Tamura","year":"2023","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.virol.2025.110584_bib84","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00493-23","article-title":"SARS-CoV-2 Co-infections and recombinations identified by long-read single-molecule real-time sequencing","volume":"11","author":"Tr\u00e9meaux","year":"2023","journal-title":"Microbiol. Spectr."},{"issue":"1","key":"10.1016\/j.virol.2025.110584_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004086","article-title":"Outcome of COVID-19 in hospitalised immunocompromised patients: an analysis of the WHO ISARIC CCP-UK prospective cohort study","volume":"20","author":"Turtle","year":"2023","journal-title":"PLoS Med."},{"issue":"3 March","key":"10.1016\/j.virol.2025.110584_bib86","article-title":"Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons","volume":"17","author":"Tzou","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2025.110584_bib87","first-page":"9","article-title":"Proliferation of SARS-CoV-2 B.1.1.7 variant in Pakistan-A short surveillance account","author":"Umair","year":"2021","journal-title":"Front. Public Health"},{"issue":"3","key":"10.1016\/j.virol.2025.110584_bib88","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/jmv.27429","article-title":"Genomic surveillance reveals the detection of SARS-CoV-2 delta, beta, and gamma VOCs during the third wave in Pakistan","volume":"94","author":"Umair","year":"2022","journal-title":"J. Med. Virol."},{"issue":"10","key":"10.1016\/j.virol.2025.110584_bib89","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1002\/jmv.27957","article-title":"Genomic diversity of SARS-CoV-2 in Pakistan during the fourth wave of pandemic","volume":"94","author":"Umair","year":"2022","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.virol.2025.110584_bib90","doi-asserted-by":"crossref","DOI":"10.1136\/bmjpo-2022-001718","article-title":"Systematic review of outbreaks of COVID-19 within households in the European region when the child is the index case","volume":"7","author":"Vardavas","year":"2023","journal-title":"BMJ Paediatr Open"},{"issue":"4","key":"10.1016\/j.virol.2025.110584_bib91","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac093","article-title":"Impact of casirivimab-imdevimab on severe acute respiratory syndrome coronavirus 2 delta variant nasopharyngeal virus load and spike quasispecies","volume":"9","author":"Vellas","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.virol.2025.110584_bib92","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/s41564-019-0465-y","article-title":"Defective viral genomes are key drivers of the virus\u2013host interaction","volume":"4","author":"Vignuzzi","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.virol.2025.110584_bib93","article-title":"Population bottlenecks and intra-host evolution during human-to-human transmission of SARS-CoV-2","volume":"8","author":"Wang","year":"2021","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.virol.2025.110584_bib94","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac676","article-title":"Association between population-level factors and household secondary attack rate of SARS-CoV-2: a systematic review and meta-analysis","volume":"10","author":"Wang","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.virol.2025.110584_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/antib12010005","article-title":"A review of the currently available antibody therapy for the treatment of coronavirus disease 2019 (COVID-19)","volume":"12","author":"Widyasari","year":"2023","journal-title":"Antibodies"},{"issue":"10","key":"10.1016\/j.virol.2025.110584_bib96","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-072280","article-title":"SARS-CoV-2 variants of concern in children and adolescents with COVID-19: a systematic review","volume":"13","author":"Wiedenmann","year":"2023","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.virol.2025.110584_bib97","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-33614-0","article-title":"Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa","volume":"13","author":"Wolter","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.virol.2025.110584_bib98","doi-asserted-by":"crossref","DOI":"10.1038\/s43856-021-00034-y","article-title":"Reduced subgenomic RNA expression is a molecular indicator of asymptomatic SARS-CoV-2 infection","volume":"1","author":"Wong","year":"2021","journal-title":"Commun. Med."},{"issue":"4","key":"10.1016\/j.virol.2025.110584_bib99","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001843","article-title":"ICTV virus taxonomy profile: Coronaviridae 2023","volume":"104","author":"Woo","year":"2023","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.virol.2025.110584_bib101","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00909-6","article-title":"Replication defective viral genomes exploit a cellular pro-survival mechanism to establish paramyxovirus persistence","volume":"8","author":"Xu","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.virol.2025.110584_bib102","article-title":"The intra-host evolution of SARS-CoV-2 after neutralizing antibody therapy, revealed by nanopore sequencing","volume":"4","author":"Zeng","year":"2024","journal-title":"Zoon"},{"issue":"16","key":"10.1016\/j.virol.2025.110584_bib103","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1021\/acs.jcim.3c00813","article-title":"Combined antibodies evusheld against the SARS-CoV-2 omicron variants BA.1.1 and BA.5: immune escape mechanism from molecular simulation","volume":"63","author":"Zhang","year":"2023","journal-title":"J. Chem. Inf. Model."},{"issue":"6","key":"10.1016\/j.virol.2025.110584_bib104","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1093\/infdis\/jiad572","article-title":"Vaccination shapes within-host SARS-CoV-2 diversity of omicron BA.2.2 breakthrough infection","volume":"229","author":"Zhang","year":"2024","journal-title":"JID (J. Infect. Dis.)"},{"issue":"3","key":"10.1016\/j.virol.2025.110584_bib105","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00250-23","article-title":"Generation and functional analysis of defective viral genomes during SARS-CoV-2 infection","volume":"14","author":"Zhou","year":"2023","journal-title":"mBio"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682225001977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682225001977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T16:55:28Z","timestamp":1753980928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682225001977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":104,"alternative-id":["S0042682225001977"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2025.110584","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drivers of quasispecies development in SARS-CoV-2 and implications for emergent variants and COVID-19","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2025.110584","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110584"}}